Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Role of oncogenic pathways and KRAS/BRAF mutations in the behavior of colon adenocarcinoma in renal transplant patients.
Revuelta I, Moya-Rull D, García-Herrera A, Rovira J, Ayala de la Peña F, Misiego A, Guzmán F, Oppenheimer F, Albanell J, Campistol JM.
Transplantation. 2012 Mar 15;93(5):509-17.
Related citations
Early association of low-grade albuminuria and allograft dysfunction predicts renal transplant outcomes.
Hernández D, Pérez G, Marrero D, Porrini E, Rufino M, González-Posada JM, Delgado P, Torres A.
Transplantation. 2012 Feb 15;93(3):297-303.
A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
Vacher-Coponat H, Moal V, Indreies M, Purgus R, Loundou A, Burtey S, Brunet P, Moussi-Frances J, Daniel L, Dussol B, Berland Y.
Transplantation. 2012 Feb 27;93(4):437-43.
Chronic kidney disease after nonrenal solid organ transplantation: a histological assessment and utility of chronic allograft damage index scoring.
Kubal C, Cockwell P, Gunson B, Jesky M, Hanvesakul R, Dronavalli V, Bonser RS, Neil D.
Transplantation. 2012 Feb 27;93(4):406-11.
Concomitant Epstein-Barr virus (EBV)-positive B-cell and EBV-negative T-cell posttransplant lymphoproliferative disorders after renal allografting: pathogenetic implications.
Au WY, Lam MF, Pang A, Leung RY, Kwong YL.
Transplantation. 2011 Dec 27;92(12):e67-8. No abstract available.
Pretransplant immune regulation predicts allograft outcome: bidirectional regulation correlates with excellent renal transplant function in living-related donor-recipient pairs.
Jankowska-Gan E, Sheka A, Sollinger HW, Pirsch JD, Hofmann RM, Haynes LD, Armbrust MJ, Mezrich JD, Burlingham WJ.
Transplantation. 2012 Feb 15;93(3):283-90.
Interaction between maintenance steroid dose and the risk/benefit of steroid avoidance and withdrawal regimens following renal transplantation.
Knight SR, Morris PJ.
Transplantation. 2011 Dec 15;92(11):e63-4. No abstract available.
It takes two to tango: both donor and recipients' immune repertoire affect outcome of renal transplants.
Claas FH.
Transplantation. 2012 Feb 15;93(3):247-8. No abstract available.
Lower prevalence of BK virus infection in African American renal transplant recipients: a prospective study.
Sood P, Senanayake S, Sujeet K, Medipalli R, Saad E, Vasudev B, Bresnahan BA, Johnson CP, Hariharan S.
Transplantation. 2012 Feb 15;93(3):291-6.
End-stage renal disease and cardiomyopathy in children: cardiac effects of renal transplantation.
Lal AK, de Biasi AR, Alexander S, Rosenthal DN, Sutherland SM.
Transplantation. 2012 Jan 27;93(2):182-7.
Blocking of CCR5 and CXCR3 suppresses the infiltration of macrophages in acute renal allograft rejection.
Kakuta Y, Okumi M, Miyagawa S, Tsutahara K, Abe T, Yazawa K, Matsunami K, Otsuka H, Takahara S, Nonomura N.
Transplantation. 2012 Jan 15;93(1):24-31.
What is the significance of subclinical inflammation in human renal allografts? It depends!
Mengel M.
Transplantation. 2012 Jan 15;93(1):22-3. No abstract available.
Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: 1-year results of a randomized clinical trial.
Witzke O, Hauser IA, Bartels M, Wolf G, Wolters H, Nitschke M; VIPP Study Group.
Transplantation. 2012 Jan 15;93(1):61-8.
Associations of ABCB1 3435C>T and IL-10-1082G>A polymorphisms with long-term sirolimus dose requirements in renal transplant patients.
Sam WJ, Chamberlain CE, Lee SJ, Goldstein JA, Hale DA, Mannon RB, Kirk AD, Hon YY.
Transplantation. 2011 Dec 27;92(12):1342-7.
Early changes in kidney function predict long-term chronic kidney disease and mortality in patients after liver transplantation.
Cantarovich M, Tchervenkov J, Paraskevas S, Ghali P, Wong P, Deschênes M, Chaudhury P, Hassanain M, Vrochides D, Metrakos P, Barkun J.
Transplantation. 2011 Dec 27;92(12):1358-63.
Successful simultaneous pancreas kidney transplantation in maturity-onset diabetes of the young type 5.
Halbritter J, Mayer C, Bachmann A, Rasche FM, Uhlmann D, Stumvoll M, Lindner TH.
Transplantation. 2011 Oct 27;92(8):e45-7. No abstract available.
Randomized trial of dual antibody induction therapy with steroid avoidance in renal transplantation.
Ciancio G, Gaynor JJ, Sageshima J, Guerra G, Zarak A, Roth D, Brown R, Kupin W, Chen L, Hanson L, Tueros L, Ruiz P, Livingstone AS, Burke GW 3rd.
Transplantation. 2011 Dec 27;92(12):1348-57.
The dual role of epithelial-to-mesenchymal transition in chronic allograft injury in pediatric renal transplantation.
Vitalone MJ, Naesens M, Sigdel T, Li L, Hseih S, Sarwal MM.
Transplantation. 2011 Oct 15;92(7):787-95.
African American living-kidney donors should be screened for APOL1 risk alleles.
Cohen DM, Mittalhenkle A, Scott DL, Young CJ, Norman DJ.
Transplantation. 2011 Oct 15;92(7):722-5.
Human leukocyte antigen antibody-incompatible renal transplantation: excellent medium-term outcomes with negative cytotoxic crossmatch.
Higgins R, Lowe D, Hathaway M, Williams C, Lam FT, Kashi H, Tan LC, Imray C, Fletcher S, Chen K, Krishnan N, Hamer R, Daga S, Edey M, Zehnder D, Briggs D.
Transplantation. 2011 Oct 27;92(8):900-6.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on